Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, August 20, 2019 · 494,075,115 Articles · 3+ Million Readers

Psoriasis Treatment Market to Exhibit 8.2% CAGR, Rising Prescription Volume for Interleukin Inhibitors Segment to Boost Market: Fortune Business Insights

Key companies covered in the Psoriasis Treatment Market Research report include Merck & Co., Inc., LEO Pharma A/S, Pfizer Inc., Sun Pharmaceutical Industries Ltd, AbbVie Inc., UCB S.A., Amgen Inc., Johnson & Johnson Services, Inc., Eli Lilly and Company, and others.

/EIN News/ -- Pune, Aug. 16, 2019 (GLOBE NEWSWIRE) -- The increasing prevalence of psoriasis around the world is boosting the global Psoriasis Treatment Market, says Fortune Business Insights in their recent report. The report is titled Psoriasis Treatment Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the report, the market will reach US$ 37,634.2 Mn by 2026 from US$ 18,378.0 Mn in 2018, exhibiting a CAGR of 8.2% between 2018 and 2026.

According to the report prepared by Fortune Business Insights, the TNF inhibitors segment emerged dominant among drug classes. In 2018, the TNF inhibitor segment held 46.3% share in the market. However, in the coming years, the market may witness higher demand for biosimilar version leading to the decline in the price of TNF inhibitors. This, accompanied by the increasing prescription volume for interleukin inhibitors segment may help the interleukin inhibitors to emerge as the dominant segment in the coming years.

Browse Complete Report Details with Table of Content and Figures:

Rising Prevalence of Plaque Psoriasis to Increase Demand for Treatment, Boosting Market

One of the major factor boosting the global Psoriasis Treatment Market is the increasing prevalence of the disease itself. The World Health Organization states that the prevalence of psoriasis is estimated to vary between 0.09% to 11.0% across all nations. This ultimately means that psoriasis is a serious problem. Psoriasis can occur to anyone irrespective of age but is usually reported to occur to aged people between 50 to 70 years. The rising geriatric population and their vulnerability towards diseases such as psoriatic arthritis are factor propelling growth of the market. These, coupled with the rising prevalence of plaque psoriasis, are likely to create growth opportunities for the market in the forecast period.

The rising availability of biologic and biosimilar products is helping the market for psoriasis grow rapidly. Increase in prescription volume of the biologic products and favorable reimbursement policies by governments are also helping the market grow and continue doing so in the forecast duration as well.

North America to Continue Dominating Market with Rapid Adoption of Biological Therapy

Fortune Business Insights foresees the global psoriasis market to witness dominance of North America followed by Europe. As per the National Psoriasis Foundation, there are about 8 million people in America living with psoriasis. Owing to its quick rate of biological therapy adoption, and rise in investments on research and development for clinical trials, North America is likely to continue dominating the global market for psoriasis in the forecast period as well.

On the other side, the emerging markets in the Middle East and Africa, Latin America, and Asia Pacific are expected to offer lucrative growth opportunities because of large patient pool, the improving healthcare infrastructure and medical facilities; increasing awareness, and with rising investments for development of new therapeutics for psoriasis.

Major companies are investing increasingly in research and development for product launches. Major strategies adopted by vendors include merger and acquisitions, research and development, and new product launches. At present, Abbvie is dominating the global Psoriasis Treatment Market and this is because of their leading product named Humira.

Sample PDF

The report analysis comprises of market dynamics and competitive landscape. Additionally, the report offers insights on the prevalence of psoriasis and psoriatic arthritis for key countries/region, recent industry developments such as partnerships, mergers & acquisitions, new product launches etc.; pipeline analysis for key companies, regulatory framework by key countries, and global reimbursement scenario.

Key Companies Covered

  • AbbVie Inc.
  • Novartis AG
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.,
  • LEO Pharma A/S
  • Merck & Co., Inc.
  • Amgen Inc.
  • Eli Lilly and Company 
  • UCB S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Other prominent players

Speak to Analyst

Table of Content:

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities

  • Key Insights
    • Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
    • Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
    • Pipeline Analysis for Key Companies
    • Regulatory Framework by Key Countries
    • Global Reimbursement Scenario

  • Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • TNF Inhibitors
      • Interleukins
      • Others
    • Market Analysis, Insights and Forecast – By Type
      • Plaque Psoriasis
      • Psoriatic Arthritis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Parenteral
      • Topical
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa
  • Competitive Analysis
  • Strategic Recommendations

Request for Customization:

Browse Related Reports:

  • Psoriatic Arthritis Treatment Market Size, Share and Global Trend by Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies) and Geography Forecast till 2026
  • Immunology Market Size, Share and Global Trend by Drug Class ( Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal antibody (pAb) ), By Disease Indication ( Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection ), By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Geography Forecast till 2025
  • Vitiligo Treatment Market Size, Share and Global Trend by Treatment (Topical Treatment, Light Therapy, Surgical Procedures, Others), By Disease Type (Nonsegmental Vitiligo, Segmental Vitiligo), By End User (Hospitals, Aesthetic Clinics, Others) and Geography Forecast till 2026

  • Botulinum Toxin Market Size, Share and Global Trend by Application (Therapeutics, Aesthetics), By End User (Specialty & Dermatology Clinics, Hospitals & Clinics), By Type(Botulinum Toxin Type A, Botulinum Toxin Type B) and Geography Forecast till 2026

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:
Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245

Primary Logo

Powered by EIN News

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release